MDS Lowers Revenue Guidance, Expects Charges Exceeding $500M for FY2008 | GenomeWeb
NEW YORK (GenomeWeb News) – MDS today lowered its revenue guidance for fiscal year 2008, one week before it will report results, to a range of $1.21 billion to $1.22 billion from its previous expectations of $1.23 billion to $1.25 billion.
The Toronto-based firm also lowered its expected adjusted EBITDA to a range of between $148 million and $154 million from a range of between $160 million and $170 million for the fiscal year, which ended Oct. 31.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.